ZBH News | Roxom Stocks

Invest Private Security Newsroom

Market Overview

Indices and commodities.

Bitcoin treasury preferreds.

The artificial intelligence theme.

Bitcoin Treasuries

Companies holding bitcoin.

Sectors, global markets and rates.

Popular Portfolios

13F filings, smart money.

Borrow USDT or USDC against your BTC without giving it up.

Switch your bitcoin-backed loan and pay less interest.

Borrow, invest, keep the spread.

Stock Dividends

Dividends from tokenized equities.

Company

Our leadership team, mission, and investors.

Vision, purpose, and architecture behind Roxom.

Terms, privacy, and disclosures.

Resources

Guides, FAQs & support.

Trading logic, platform rules, and fundamentals.

Connect, authenticate, and build with our API.

Current platform health and incidents.

Loading chart

Pay with

1 BTC

=

- USD

Loading market data...

Loading chart

Pay with

ZB

Mkt Cap

$18.12B

Volume

1.27M

Next Earnings

November 4th

Loading chart

ZB

ZBHZimmer Biomet Holdings, Inc.

ZBH

Pay with—

Available Balance0.00

ZB

Mkt Cap

$18.00B

Volume

1.27M

Next Earnings

November 4th

Chart Financials Earnings News About Dividends Insider Filings

Should Value Investors Buy Zimmer Biomet (ZBH) Stock?Zimmer Biomet (ZBH) is identified as an attractive value stock with a Zacks Rank #2 (Buy) rating and an 'A' Value grade. The company trades at a P/E ratio of 11.98, below its industry average of 15.93, and demonstrates solid valuation metrics across P/B and P/CF ratios, suggesting it may be undervalued relative to its earnings outlook.Zacks Investment Research · Oct 12, 2026

Zimmer Biomet (ZBH) is a Top-Ranked Value Stock: Should You Buy?Zimmer Biomet (ZBH), a musculoskeletal healthcare company, has been identified as a #2 (Buy) on the Zacks Rank with a VGM Score of B and Value Style Score of A. The company features attractive valuation metrics with a forward P/E ratio of 10.51, and analysts have revised earnings estimates higher, with the consensus estimate at $8.54 per share and an average earnings surprise of +4.5%.Zacks Investment Research · Oct 7, 2026

Are Investors Undervaluing Baxter International (BAX) Right Now?Zacks highlights two Medical-Products stocks with strong value characteristics: Baxter International (BAX) and Zimmer Biomet (ZBH), both holding Zacks Rank #2 (Buy) ratings and Value grade A. Both stocks trade at attractive valuations compared to industry averages across multiple metrics including P/E, PEG, P/B, and P/S ratios, suggesting they are currently undervalued with strong earnings outlooks.Zacks Investment Research · Oct 6, 2026

Pacira (PCRX) Up 6.9% Since Last Earnings Report: Can It Continue?Pacira (PCRX) reported Q2 2026 adjusted earnings of 73 cents per share, beating consensus estimates of 64 cents, with revenues of $192.4 million exceeding expectations. However, the company lowered its 2026 total revenue guidance to $735-$760 million from $745-$770 million following the divestiture of iovera to Zimmer Biomet. Despite the earnings beat, estimates have been trending downward, and the stock received a Zacks Rank #3 (Hold) rating with expectations for in-line returns.Zacks Investment Research · Sep 3, 2026

Explosive Growth in AI for Orthopedic Surgery Market: $0.87 Billion by 2030 at 27.2% CAGRThe AI in orthopedic surgery market is experiencing remarkable growth with a projected CAGR of 27.2% through 2030. Key drivers include rising musculoskeletal disorders, AI-assisted surgical planning, robotic surgical systems integration, and enhanced implant placement precision. North America leads the market, while Asia-Pacific and Europe show growing segments despite tariff-related challenges.GlobeNewswire Inc. · Jul 10, 2026

Surgical Navigation System Report; Patent Leadership Led by the United States with 1,204 Patents In 230-Page Patent Landscape Covering Neurosurgery, Spinal, Orthopaedic, ENT, and Dental Navigation ApplicationsA comprehensive patent landscape analysis of surgical navigation systems reveals 2,524 patents filed globally from 2010-2025, with the United States leading at 1,204 patents. The global market was valued at USD 8.38 billion in 2024 and is projected to reach USD 18.47 billion by 2030 at a 14% CAGR. Key drivers include AI-guided support, augmented reality, and robotic integration, with North America dominating and Asia-Pacific as the fastest-growing region. Major players include Brainlab AG, Medtronic, and Stryker.GlobeNewswire Inc. · Jul 9, 2026

Wound Irrigation Systems Market to Skyrocket USD 430.05 Million by 2035 as Chronic Wound Cases and Surgical Volumes Rise Worldwide | SNS InsiderThe global wound irrigation systems market is projected to grow from USD 307.87 million in 2025 to USD 430.05 million by 2035, with a CAGR of 3.55%. Growth is driven by rising chronic wound prevalence, increased surgical volumes, and innovations in pulsatile lavage systems. North America leads with 40% market share, while Asia Pacific shows the fastest growth at 4.7% CAGR. Manual systems currently dominate with 53% market share, though battery-operated systems are expected to grow fastest.GlobeNewswire Inc. · Jun 3, 2026

Zimmer Biomet Announces Quarterly Dividend for Second Quarter of 2026Zimmer Biomet Holdings announced that its Board of Directors approved a quarterly cash dividend of $0.24 per share for Q2 2026, payable on or about July 31, 2026 to stockholders of record as of June 25, 2026.Benzinga · May 22, 2026

Tissue Engineering Market to Grow at 12.95% CAGR Reaching USD 27.59 Billion by 2031, Driven by Advances in Regenerative Medicine and Biomaterials, Says Mordor IntelligenceThe global tissue engineering market is projected to grow from USD 15.01 billion in 2026 to USD 27.59 billion by 2031, driven by advancements in regenerative medicine, biomaterials, and stem cell research. Key growth drivers include increasing demand for regenerative therapies, innovations in 3D bioprinting, rising prevalence of chronic diseases, and expanding applications in orthopedics, skin regeneration, and dental restoration. North America leads the market while Asia-Pacific emerges as a high-growth region.GlobeNewswire Inc. · Apr 24, 2026

[Latest] Global Surgical Drill Bits Market Size/Share Worth USD 540 Million by 2035 at a 5.5% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)The global surgical drill bits market was valued at USD 316 million in 2025 and is projected to reach USD 540 million by 2035, growing at a CAGR of 5.5%. Growth is driven by healthcare infrastructure development in emerging economies, increased surgical procedures, and rising demand for infection prevention measures. Hospitals are expected to dominate the market segment, while North America leads in market share and Asia-Pacific shows the highest growth rate.GlobeNewswire Inc. · Apr 21, 2026

to start trading

ZB

ZBHZimmer Biomet Holdings, Inc.

ZBH

Pay with—

Available Balance0.00

Your PositionYou don't own any ZBH yet.

Related Tickers

Earnings

Dividends

Last · Sep 30Quarterly

Amount$0.24

Yield1.01%

Annual$0.96